Radicicol as a Dual-Site Inhibitor of Isoprenylcysteine Carboxyl Methyltransferase: A Computational Study

雷迪西醇作为异戊二烯基半胱氨酸羧基甲基转移酶的双位点抑制剂:一项计算研究

阅读:1

Abstract

BACKGROUND: Isoprenylcysteine carboxyl methyltransferase (ICMT) is an enzyme crucial for the post-translational processing of Ras oncoproteins. Pharmacological inhibition of ICMT can mislocalize Ras and disrupt oncogenic signaling, exhibiting anticancer effects. Radicicol (RAD) is a 14-membered resorcylic acid lactone biosynthesized by fungi and possesses diverse bioactivities. OBJECTIVE: The current work explored RAD's interaction with ICMT through molecular docking and molecular dynamics simulations, comparing Radicicol's binding mode to that of the native ICMT ligand. METHOD: Docking simulations were performed using Glide XP mode, and binding energies were refined by MM-GBSA calculations. Molecular dynamics simulation of 100 ns was conducted to assess the binding stability of the Radicicol-ICMT complex using Desmond, with analysis of RMSD and protein-ligand interactions. RESULTS: Molecular docking and molecular dynamics simulations revealed that RAD stably bound within the ICMT active site by bridging both the S-adenosylmethionine cofactor pocket and the hydrophobic prenyl substrate tunnel. Its key interactions included a persistent hydrogen bond with Val116 and an induced-fit engagement of Arg125, supporting a snug and stable RAD-ICMT complex. CONCLUSION: These computational insights suggested that RAD inhibited ICMT by dual-site binding, simultaneously occupying the cofactor and substrate pockets. Such a dual engagement could mislocalize prenylated proteins (like Ras) and represent a novel mechanism of action for RAD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。